Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03392038 · ClinicalTrials.gov registry record · NA
Thick vs. Thin Acellular Dermal Matrix (ADM)
A NA study of Gingival Recession, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03392038: Completed NA study of Gingival Recession, sponsored by University of Louisville.
NCT03392038 is a NA study of Gingival Recession that has completed, run by University of Louisville. The registered enrollment target is 22 participants, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03392038, a NA study of Gingival Recession, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique.
Primary Outcome
Between 0 and 100%
Conditions Studied
Interventions
- PROCEDURE Thin ADM
- PROCEDURE Thick ADM
Study Locations (1)
Kentucky
- Graduate Periodontics, UofL School of Dentistry - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2018-08-21 |
| Phase | NA |
What the finished NCT03392038 record still lists
NCT03392038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which Thin ADM is the first listed.
NCT03392038 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03392038 about?
NCT03392038 is a clinical study titled "Thick vs. Thin Acellular Dermal Matrix (ADM)". To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique.
What is the current status of trial NCT03392038?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-11-30. Estimated completion is 2018-08-21.
What conditions does trial NCT03392038 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT03392038?
The interventions under investigation include: Thin ADM (PROCEDURE), Thick ADM (PROCEDURE).
Who is sponsoring clinical trial NCT03392038?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03392038 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03392038's enrollment target sits among peer trials
22 8th of 10 higher than 2 of 10 other Gingival Recession trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
-
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI